NCT01592331View on ClinicalTrials.gov

A Pharmacodynamic and Pharmacokinetic Study of RO5508887 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

Placebo

Single oral dose

DRUG

RO5508887

Single oral dose

Trial Locations (1)

91206

Glendale

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01592331 - A Pharmacodynamic and Pharmacokinetic Study of RO5508887 in Healthy Volunteers | Biotech Hunter | Biotech Hunter